Qualitative MRI: Evidence of usual aging in the brain

Topics in Magnetic Resonance Imaging

Volumn 15, Issue 6, 2004, Pages 343-347

  Kapeller, Peter ^a   Schmidt, Reinhold ^a   Fazekas, Franz ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Age; Magnetic resonance imaging; White matter

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

AGED; AGING; BASAL GANGLION; BASAL GANGLION DARKENING; BRAIN; BRAIN ATROPHY; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN METABOLISM; BRAIN TISSUE; FIBRINOLYTIC THERAPY; HUMAN; LIFE EXPECTANCY; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITATIVE ANALYSIS; REVIEW; SIGNAL PROCESSING; VIRCHOW ROBIN SPACE; WHITE MATTER; WHITE MATTER INTENSITY;

AGING; BASAL GANGLIA; BRAIN; CEREBRAL HEMORRHAGE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 23244451817     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rmr.0000172668.02575.18     Document Type: Review

References (41)

1. Fazekas F, Chawluk I, Alavi A, et al. MRI signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol. 1987;8:421-426.
2. Schenk J, Zimmerman E. High field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed. 2004;17:433-445.
3. Greenberg S, Finkelstein S, Schaefer P. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient echo MRI. Neurology. 1996;46:1751-1754.
4. Ugawa Y, Shirouzu I, Terao Y, et al. Physiological analyses of a patient with extreme widening of Virchow Robin spaces. J Neurol Sci. 1998;159:25-27.
5. Brooks J, Roberts N, Kemp G, et al. A proton magnetic resonance spectroscopy study of age related changes in frontal lobe metabolite concentrations. Cereb Cortex. 2001;11:598-605.
6. Fazekas F, Ropele S, Bammer R, et al. Novel imaging technologies in the assessment of cerebral ageing and vascular dementia. J Neural Transm Suppl. 2000;59:45-52.
7. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol. 1989; 29:164-168.
8. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683-1689.
9. Scheltens P, Barkhof F, Leys D, et al. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology. 1995;45:883-888.
10. Awad I, Spetzler R, Hodak J, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke. 1986;17:1084-1089.
11. Schmidt R. Fazekas F, Kapeller P, et al. MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology. 1999;53:132-139.
12. Schmidt R, Enzinger C, Ropele S, et al. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study Lancet. 2003;361:2046-2048.
13. Schmidt R, Fazekas F, Kleinert G, et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol. 1992;49:825-827.
14. Fazekas F, Kleinert R, Offenbacher H, et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol. 1991;12:915-921.
15. Sze G, De Armond S, Brant-Zawadzki M, et al. Foci of MRI signal (pseudo lesions) anterior to the frontal horns: histologic correlations of a normal finding. AJNR Am J Neuroradiol. 1986;17:381-387.
16. Leifer D, Buonnano F, Richardson EJ. Clinicopathologic correlations of cranial magnetic resonance imaging of periventricular white matter. Neurology. 1990;40:911-918.
17. Smith C, Markesbery W, Snowdon D. Periventricular white matter hyperintensities on MRI: correlation with neuropathologic findings. J Neuroimaging. 2000;10:13-16.
18. Schmidt R, Schmidt H, Fazekas F, et al. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities. Hypertension. 2001;38:110-115.
19. van Dijk E, Breteler M, Schmidt R, et al. The association between blood pressure, hypertension and cerebral white matter lesions: Cardiovascular Determinants of Dementia Study. Hypertension. 2004;44:625-630.
20. van Dijk E. Causes of cerebral small vessel disease-a prospective population based MRI study [thesis]. Rotterdam: Erasmus Medical Center; 2004.
21. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss in gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999;20:637-642.
22. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population: the Austrian Stroke Prevention Study. Neurology. 1999;52:991-994.
23. Roob G, Lechner A, Schmidt R, et al. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke. 2000;31:2665-2669.
24. Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol. 1996;17:573-578.
25. SPIRIT SG. A randomised trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. Ann Neurol. 1997;42:857-865.
26. Lesnik Oberstein S, van den Boom R, van Buchem M. et al. Cerebrak microbleeds in CADASIL. Neurology. 2001;57:1066-1070.
27. van den Boom R, Lesnik Oberstein S, Ferrari M, et al. CADASIL: MR imaging findings at different ages-3rd to 6th decades. Radiology. 2003; 229:683-690.
28. Greenberg S. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology. 1998;51:690-694.
29. Bartzokis G, Tishler T, Shin I, et al. Brain ferritin iron as a risk factor for age at onset in neurodegenerative disease. Ann N Y Acad Sci. 2004;1012:224-236.
30. Avrahami E, Cohn D, Feibel M, et al. MRI demonstration and CT correlation of the brain in patients with idiopathic intracerebral calcification. J Neurol. 1994;241:381-384.
31. Kanamella U, Calabro F, Jinkins J. Cavernous dilatation of mesencephalic Virchow-Robin spaces with obstructive hydrocephalus. Neuroradiology. 2000;42:881-884.
32. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol Neurosurg Psychiatry. 1998; 245:116-122.
33. Resnick S, Pham D, Kraut M, et al. Longitudinal MRI studies of older adults: a shrinking brain. J Neurosci. 2003;23:3295-3301.
34. Scahill R, Frost C, Jenkins R, et al. A longitudinal study of brain volume changes in normal aging using serial registered MRI. Arch Neurol. 2003;60:989-994.
35. Enzinger C, Fazekas F, Matthews R et al. Risk factors for progression of atrophy in aging: Six-year follow-up of normal subjects. Neurology. 2005;64(10):1704-1711.
36. Bruhn H, Stoppe G, Merboldt K, et al. Cerebral metabolic alterations in normal aging and Alzheimers dementia detected by proton magnetic resonance spectroscopy. Proceedings of the 11th Meeting of ISMRM. 1992;1:752.
37. Fukuzako H, Hashiguchi T, Sakamoto J, et al. Metabolic changes with age measured by IHMRS in normal subjects. Psychiatry Clin Neurosci. 1997;51:261-263.
38. Chang L, Ernst T, Poland R, et al. In vivo IHMRS of the normal aging human brain. Life Sci. 1996;58:2049-2056.
39. Soher B. van Zijl P, Duyn J, et al. Quantitative IHMRSI of the human brain. Magn Reson Med. 1996;35:356-363.
40. Pfefferbaum A, Adalsteinsson E, Spielman S, et al. In vivo spectroscopic quantification of the NA-moiety, creatine and choline from large volumes of brain gray and white matter: effects of normal aging. Magn Reson Med. 1999;41:276-284.
41. Leary S, Brex P, MacManus D, et al. A 1HMRS study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Med. 2000;18:455-459.